Overview
PharVision Advisers, LLC (“PharVision”) is an investment advisory firm organized as a limited
liability company under the laws of the State of Delaware. Blagovest Baychev and Philip
Arnaudov, the principal owners of PharVision, founded the company in October 2020. PharVision
owned and controlled by Mr. Baychev and Mr. Arnaudov.
PharVision provides investment advisory services on a discretionary basis to high net worth
individuals and institutional investors through privately offered pooled investment vehicles (each
a “Fund” or collectively the “Funds”), and separately managed accounts (each a “Managed
Account,” and collectively, the “Managed Accounts”). Each Fund and Managed Account may be
referred to herein as a “Client” or collectively, the “Clients.”
In providing such services to the Clients, PharVision has discretion, subject to the terms of the
Clients’ Governing Documents (as defined below), to formulate investment objectives, direct and
manage the investment and reinvestment of the Clients’ assets.
Terms of investments, including Client objectives, limitations and strategies are governed
exclusively by the terms of the private placement memorandum, limited partnership or operating
agreement, and/or an investment management agreement, as applicable (collectively, the
“Governing Documents”). PharVision offers the same and different suites of services to its Clients.
Specific Client investment strategies and their implementation are dependent upon the Client’s
investment objectives. Managed Account Clients may impose restrictions on investing in certain
securities or types of securities. Investors in the Funds (“Investors”) cannot generally place
investment restrictions on PharVision and may not tailor PharVision’s advisory services to their
individual needs.
Please see Item 8 (Methods of Analysis, Investment Strategies, and Risk of Loss) for more
information.
As of December 31, 2022, PharVision managed approximately $270 million in discretionary and
$0 in non-discretionary assets.